Urohealth buys Microsurge in stock swap:
This article was originally published in Clinica
Urohealth Systems has purchased Microsurge for $29 million in stock and the assumption of $9 million of debt. Microsurge manufactures multi-use instruments for minimally-invasive procedures such as laparoscopy and thoracoscopy. Microsurge is already on the market with two product lines, DetachaTip scissors, graspers and dissectors, and DetachaPort trocars.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.